Tulis D A, Keswani A N, Peyton K J, Wang H, Schafer A I, Durante W
Cardiovascular Disease Research Program, J.L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, North Carolina 27707, USA.
Cell Mol Biol (Noisy-le-grand). 2005 Oct 3;51(5):441-6.
Recent studies indicate that systemic induction of heme oxygenase-1 (HO-1), which oxidatively degrades heme into iron, biliverdin, and carbon monoxide (CO), or adenoviral-mediated gene transfer of HO-1 inhibits neointima formation after experimental vascular injury. In the present study, we investigated whether the acute, local administration of the HO-1 product, CO, regulates the arterial remodeling response following injury. Immediately after balloon injury of rat carotid arteries, a saturated solution of CO or nitrogen (N2), or phosphate buffered saline (PBS) was incubated luminally within the injured vessels for 30 min. Two weeks after injury, arteries exposed to CO exhibited significantly reduced neointimal area, neointimal area/medial wall area ratio, neointimal thickness, and medial wall area compared to arteries exposed to N2 or PBS. Arteries exposed to CO also demonstrated significantly reduced DNA synthesis in the medial wall two days after injury as suggested by proliferating cell nuclear antigen immunostaining, and this was associated with a decrease in the protein expression of the G1 cyclins, cyclin E and A, and transforming growth factor-beta1. These results indicate that the acute, local delivery of CO blocks the pathophysiological remodeling response to vascular injury, and identifies CO as a potentially important therapeutic agent in the treatment of vasculoproliferative disease.
最近的研究表明,全身性诱导血红素加氧酶-1(HO-1)(其可将血红素氧化降解为铁、胆绿素和一氧化碳(CO))或腺病毒介导的HO-1基因转移可抑制实验性血管损伤后的内膜增生。在本研究中,我们调查了HO-1产物CO的急性局部给药是否能调节损伤后的动脉重塑反应。在大鼠颈动脉球囊损伤后立即将CO或氮气(N2)的饱和溶液或磷酸盐缓冲盐水(PBS)腔内注入损伤血管中30分钟。损伤后两周,与暴露于N2或PBS的动脉相比,暴露于CO的动脉内膜面积、内膜面积/中膜壁面积比、内膜厚度和中膜壁面积均显著减小。如增殖细胞核抗原免疫染色所示,暴露于CO的动脉在损伤后两天中膜壁的DNA合成也显著减少,这与G1细胞周期蛋白、细胞周期蛋白E和A以及转化生长因子-β1的蛋白表达降低有关。这些结果表明,CO的急性局部递送可阻断对血管损伤的病理生理重塑反应,并确定CO为血管增殖性疾病治疗中一种潜在的重要治疗剂。